Fundraising Fox
🦊/Companies
Sign in

ProteinQure

Toronto, CA · Founded 2017 · 32 employees on LinkedIn · 5 known investors

Find your way into ProteinQure

260 people in our graph share verified history with the ProteinQure team — schools, employers, funds. One of them is your warm intro.

Angelaunlockedknows Tomas Babej · together at Creative Destruction Lab (overlapped)
×11knows the team · via Creative Destruction Lab

ProteinQure is a clinical-stage biotech company that designs novel peptides for therapeutic delivery using its proprietary ProteinStudio computational platform powered by AI and molecular simulations. The company focuses on peptide-drug conjugates for tissue-specific and cell-specific delivery of therapeutics, with applications in oncology, renal disease, and blood-brain barrier transport.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

ProteinQure was founded in 2017 by Tomas Babej.

TBTomas Babej
Tomas BabejinCofounder and Chief Technology OfficerTomas Babej studied theoretical computer science, machine learning, quantum computing, and cybersecurity at the university, and has contributed thousands of commits to open source projects including work with RedHat during his software engineering career. He is founder of ProteinQure, a biotech company developing a computational platform for protein therapeutic design.

Investors · 5

Golden VenturesToronto · $500K – $2.5M
Intrepid Growth PartnersToronto
Kensington Capital Partners LimitedToronto
Felicis VenturesreportedSan Francisco · $500K – $15M

Also in the syndicate · 1

Heron Rock Fundlead

Funding

SEC filings, press & company announcements

$11M disclosed across 1 round · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

ProteinQure Raises Series A Financing to Advance First AI-Designed Peptide Therapeutic into Clinical Trialsfinance.yahoo.com · May 2025ProteinQure 5/28/2025 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com · May 2025ProteinQure Closes $11M in Series A Financingfinsmes.com · May 2025ProteinQure Raises Series A Financing to Advance First AI-Designed Peptide Therapeutic into Clinical Trials - BioSpacebiospace.com · May 2025Exclusive: Toronto biotech ProteinQure nears the clinic with peptide platform as it raises $11M Series Aendpoints.news · May 2025ProteinQure Raises $4M in seed Funding - FinSMEsfinsmes.com · Jul 2019ProteinQure raises $4M seed round to unlock potential of protein therapeuticsmedium.com · Jul 2019

Frequently asked questions

What does ProteinQure do?
ProteinQure is a clinical-stage biotech company that designs novel peptides for therapeutic delivery using its proprietary ProteinStudio computational platform powered by AI and molecular simulations. The company focuses on peptide-drug conjugates for tissue-specific and cell-specific delivery of therapeutics, with applications in oncology, renal disease, and blood-brain barrier transport.
Who founded ProteinQure?
ProteinQure was founded by Tomas Babej in 2017.
Who are ProteinQure's investors?
ProteinQure's investors include Golden Ventures, Intrepid Growth Partners, Kensington Capital Partners Limited, Felicis Ventures.
How much funding has ProteinQure raised?
ProteinQure has disclosed $11M raised across 1 round.
Where is ProteinQure headquartered?
ProteinQure is headquartered in Toronto, CA.